PM Case 1: Sesame

Adam Greenbaum, MD, joined Emory after serving at Henry Ford Heart and Vascular Institute in... Adam Greenbaum, MD, joined Emory after serving at Henry Ford Heart and Vascular Institute in Detroit, Michigan for the past 19 years as Co-director of the Center for Structural Heart Disease, Director of the Cardiac Catheterization Laboratory and Director of the Interventional Fellowship Program. He has dedicated his career to patient care, clinical research and fellow and resident education. Dr. Greenbaum has received numerous patient care and teaching awards, and is recognized as a clinical expert in the field of structural heart disease. His breakthrough research surrounding structural heart problems and the minimally invasive techniques he developed as a result, gives patients new treatment options. And his novel transcatheter methods and approaches to valvular heart disease bring new hope to patients with no other options. He is board certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions. Dr. Greenbaum graduated from the New York University School of Medicine in New York, NY. He completed his internal medicine training at the University of Michigan in Ann Arbor, MI and his general and interventional cardiology training at Duke University in Durham, NC. Read more Show less

A staff clinician, adult interventional cardiologist at National Heart Lung and Blood Institute... A staff clinician, adult interventional cardiologist at National Heart Lung and Blood Institute at NIH. Features in 3 videos on Cerebria. Christopher G. Bruce generally speaks on Live Cases. Read more Show less

Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC).... Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC). Dr. Leon is also Director of Columbia Interventional Cardiovascular Care, Director of the Cardiac Catheterization Laboratories, and is on the Executive Board of the Columbia Structural Heart & Valve Center. He is a practicing interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation. Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Dr. Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 24th anniversary. Dr. Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens. Read more Show less

Vasilis Babaliaros, MD is Professor of Medicine and Surgery at Emory University School of... Vasilis Babaliaros, MD is Professor of Medicine and Surgery at Emory University School of Medicine, and Co-Director of the Emory Structural Heart and Valve Center. He received his bachelor of science in biomedical engineering, summa cum laude, from Duke University, and his medical degree, magna cum laude, from Emory University. He also completed his training in Internal Medicine, Cardiology and Interventional Cardiology at Emory University. He received advanced training in valvular intervention under the direction of Alain Cribier at the University of Rouen, France before returning to Emory to join the faculty. His research interests include percutaneous cardiac valve repair and replacement as well as treatment of structural and congenital heart disease. Read more Show less